Key Takeaways
- UBS moved Tesla ($TSLA) to Neutral from Sell, maintaining a $352 price target
- The electric vehicle maker’s shares declined over 21% in 2026, lagging major indices
- UBS projects 1.6 million vehicle deliveries for 2026 with modest growth trajectory to 2030
- The robotaxi rollout faces delays; Optimus humanoid robot production likely to trail Musk’s timeline
- Analyst Joseph Spak notes the stock responds more to narrative shifts than financial metrics
UBS has revised its stance on Tesla (TSLA) shares to Neutral from Sell, pointing to a more favorable risk-reward equation after the stock’s significant 2026 pullback.
Analyst Joseph Spak maintained the $352 price objective while making the rating change. The adjustment follows a year-to-date decline exceeding 21% for Tesla shares, substantially trailing the performance of broader equity benchmarks.
Spak explained that the current valuation better reflects the balance between immediate challenges and the company’s potential in physical artificial intelligence applications over the coming years.
Multiple factors have created headwinds for the shares. Softer electric vehicle market conditions, disappointing first-quarter energy segment results, expanding cost pressures, and elevated capital expenditure plans have combined to pressure the stock.
Development of Tesla’s two highest-profile initiatives — the autonomous taxi platform and the Optimus humanoid robot — has proceeded at a pace below many observers’ expectations.
While upgrading the rating, Spak delivered a tempered assessment of near-term prospects. He cautioned that the shares “may continue to exhibit high volatility” and emphasized that price movements tend to follow sentiment and storylines rather than fundamental business metrics.
Regarding delivery figures, UBS anticipates 1.6 million vehicle handovers in 2026 — essentially matching the prior year. The firm projects a 7% compound annual growth rate reaching approximately 2 million units by 2030. This forecast falls considerably below Wall Street’s consensus estimate, which approaches 3 million vehicles.
Spak attributed the conservative delivery projection to intensifying pressure from Chinese competitors, subdued domestic EV adoption, and a limited model range.
Robotaxi Deployment Lags Expectations
Tesla had signaled plans to operate its autonomous taxi service across nine metropolitan areas during the first half of 2026. However, Spak expressed concern about the sluggish expansion beyond Austin.
He anticipates limited near-term scaling. Over a longer horizon, UBS maintains the view that Tesla could deliver competitively priced transportation per mile and capture significant share of the U.S. robotaxi sector.
Optimus Production Timeline Faces Headwinds
Regarding Optimus, Spak offered a restrained perspective. He indicated the initiative “will take longer than Musk’s stated targets” and highlighted supply chain vulnerabilities stemming from current dependence on Chinese component suppliers.
UBS models approximately 5,000 Optimus units during 2027, climbing to 30,000 by the decade’s end. These figures represent a fraction of Musk’s stated goals for volume manufacturing beginning next year.
From a valuation perspective, applying a 150x price-to-earnings ratio, Tesla’s present share price suggests $2.33 in 2027 earnings per share. UBS forecasts $2.35; the Street consensus stands at $2.47.
Tesla’s current P/E ratio of 325 appears elevated compared to fair value assessments from multiple financial data services.
The Netherlands recently granted regulatory approval for Tesla’s Full Self-Driving system on both highways and urban roads — the first European nation to do so. Cantor Fitzgerald referenced this development when maintaining its Overweight rating with a $510 price target.
